From gut to liver: Exploring the relationship between inflammatory bowel disease and metabolic dysfunction-associated steatotic liver disease

Figure 1 Cardiometabolic criteria for the diagnosis of metabolic dysfunction-associated steatotic liver disease in adults. Diagnosis requires the presence of at least one of the following conditions: Altered body composition (body mass index ≥ 25 kg/m² or increased waist circumference adjusted for sex and ethnicity), elevated blood pressure, signs of insulin resistance (type 2 diabetes mellitus or markers), or dyslipidemia (use of lipid-lowering medication, reduced high-density lipoprotein-cholesterol, or elevated triglycerides). Adapted from the Delphi Consensus Statement (2023). BMI: Body mass index; BP: Blood pressure; DM: Diabetes mellitus; HbA1c: Glycated hemoglobin; HDL: High-density lipoprotein; MASLD: Metabolic dysfunction-associated steatotic liver disease; WC: Waist circumference.